FARM5110 – Industrial Pharmacy
Course content
The course will provide the students with in-depth knowledge of research and development (R&D) from explorative phase (medicinal chemistry, pre-clinical in vitro and in vivo studies of effect and toxicity, pre-formulation) to optimization of formulation, pilot-plant and production scale-up, as well as regulatory framework. Methods to identify and develop qualitatively good drug candidates in drug discovery and development are central. Important concepts and principals in modern pharmaceutical industry, such as QbD (Quality-by-Design) and PAT (Process Analytical Technology) will be discussed.?
Learning outcome
After completing the course:
- You have advanced knowledge of modern industrial research, development and production of new drug substances and products.
- You have in-depth knowledge of relevant modern technology, principals and models for rational industrial R&D.
- You can in collaboration prepare and present suggestions to solve complex R&D challenges.
- You can communicate about professional challenges and interventions with a broad range of professions and experts (e.g. chemists, physicians, biologists, molecular biologists, regulatory affair specialists).
- You can analyze challenges within a chosen area of specialization (medicinal chemistry, pre-clinical efficacy and safety, pharmaceutical technology including regulatory pharmacy) and independently suggest evidence-based answers.
Admission to the course
The course is mainly open to students who have been admitted to the 5-year Master`s Programme in Pharmacy at the Department?of Pharmacy, University of Oslo. In the event that space is available, other master`s level students may apply. Knowledge in relevant subject area corresponding to the content of Semester 1 through 7 at the Department’s Master`s Programme in Pharmacy is required. For more information, please contact the Study Administration at the Department of Pharmacy, studieinfo@farmasi.uio.no.
Formal prerequisite knowledge
Passed the exam in:
- FARM1100 – Pharmaceutical Chemistry
- FARM1110 – Pharmacology, Physiology and Cell Biology 1
- FARM1120 – Social Pharmacy
- FARM1130 – Pharmaceutically Based Organic Chemistry
- FARM1140 – Pharmacology, Physiology and Cell Biology 2
- FARM1150 – Pharmaceutical Based Biochemistry
- FARM2100 – Medicinal Chemistry
- FARM2110 – Pharmacotherapy 1
- FARM2120 – Pharmaceutics and Biopharmaceutics
- FARM2130 – Pharmaceutical Analytical Chemistry
- FARM2140 – Pharmaceutical Microbiology
- FARM2150 – Formulation of Drugs and Quality Assurance in Drug Production
- FARM3100 – Pharmacognosy
- FARM3110 – Pharmacotherapy 2 and Physiology 3
- FARM3120 – Medicine Use and Public Health
- FARM3130 – Advanced Pharmacy Practice Experience (APPE)
- the compulsory HSE-courses HMS0501 – Safety and Physical Environment, HMS0502 – Positive Learning Environment, HMS0503 – Laboratory Safety, HMS0506 – Patient Clinic Safety and HMS0507 – Fire Safety required for students at the 5-year Master`s Programme in Pharmacy.
Approved the compulsory parts of:
- FARM4100 – Personalised Drug Therapy
- FARM4110 – Comprehensive Biopharmacy and Formulation Technology
- FARM4120 – Drug Development
Formal prerequisite knowledge for students admitted to Studiel?p for farmas?yter med mastergrad fra land utenfor EU/E?S (only in Norwegian):
- FARM4910K – Farmakoterapi og samfunnsfarmasi med fokus p? norske terapitradisjoner og norske forhold
- FARM4920K – Fra virkestoff til ferdig formulering med fokus p? avanserte legemiddelformer
- FARM4930K – Kvalitetssikring ved produksjon og klinisk utpr?vning av legemidler
- approved the compulsory HMS-courses HMS0501 – Safety and Physical Envir